| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-07 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |